Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone Plus Levothyroxine for RPL and RIF with Thyroid Autoimmunity
NCT06641440Phase 4Completed
- Sponsor
- Centre for Endocrinology and Reproductive Medicine
- Start
- Jan 2018
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone in recurrent pregnancy loss (RPL), Recurrent Implantation Failure (RIF), sponsored by Centre for Endocrinology and Reproductive Medicine. Started Jan 2018; status: completed.
02
Drugs
prednisone
03
Conditions
recurrent pregnancy loss (RPL)Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT06641440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06641440.